Indegene’s wholly owned subsidiary -- Indegene, Inc. (USA) has signed a share purchase agreement (SPA) with Trilogy Writing and Consulting GmbH on December 31, 2025, to acquire 100% equity shares in Trilogy Writing & Consulting Inc. (formerly known as Trilogy Writing and Consulting ULC (Canada)), wholly owned subsidiary of Trilogy Writing and Consulting GmbH. The cost of the acquisition is EUR 329,014.00. Trilogy Writing and Consulting GmbH is also the wholly owned subsidiary of the company.
Consequent to the above Trilogy Writing & Consulting Inc. will cease to be the subsidiary of Trilogy Writing and Consulting GmbH and become the wholly owned subsidiary of Indegene, Inc.
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 404.75 |
| Indegene | 490.05 |
| CMS Info Systems | 298.60 |
| JITF Infralogistics | 333.50 |
| Sagility | 42.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: